PATENT CLAIM ANALYSIS

Application Number: 16007095
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "489000"]

Abstract:
Disclosed herein are compositions and methods for treating lung disorders including lung tumors by pulmonary administration of compositions comprising taxane particles such as docetaxel or paclitaxel particles.

Claim (Index 1):
A method for treating a lung disorder, including but not limited to a lung tumor or pulmonary fibrosis, comprising pulmonary administration to a subject with a lung disorder of an amount effective of a composition comprising taxane particles to treat the lung disorder, wherein the taxane particles comprise at least 95% of the taxane and have a mean particle size (number) of between 0.1 \u03bcm and 5 \u03bcm.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 94.0
- Lexical Diversity: 1.12
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15895197', '15174505', '13779625', '12436697', '15460552']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.672780871570001
- 35 USC 102 Novelty (BERT): 0.5263326135850294
- Combined Prediction Score: 0.6581360457715038
- Mean Citation Score: 270.84776600000004
- Max Citation Score: 316.4046600000001
- Similarity Product: 173.3710007075787

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test